These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 22078416

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL, Lin WC, Yeh CC, Sun YT.
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, Wang G.
    J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
    Infantino M, Manfredi M, Grossi V, Benucci M, Morozzi G, Tonutti E, Tampoia M, Bizzaro N.
    Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
    [Abstract] [Full Text] [Related]

  • 11. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
    Yamaguchi K, Tang Q, Poland P, Reay DP, Gregory A, Aggarwal R, Oddis CV, Ascherman DP.
    Front Immunol; 2024 Dec; 15():1399451. PubMed ID: 38895121
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.
    Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group.
    Ann Rheum Dis; 2019 Jul 01; 78(7):988-995. PubMed ID: 31018961
    [Abstract] [Full Text] [Related]

  • 15. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
    Trallero-Araguás E, Grau-Junyent JM, Labirua-Iturburu A, García-Hernández FJ, Monteagudo-Jiménez M, Fraile-Rodriguez G, Les-Bujanda I, Rodriguez-Carballeira M, Sáez-Comet L, Selva-O'Callaghan A, IIM Study Group and Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI).
    Semin Arthritis Rheum; 2016 Oct 01; 46(2):225-231. PubMed ID: 27139168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P, André C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C.
    Autoimmun Rev; 2011 Jul 01; 10(9):509-13. PubMed ID: 21447407
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
    Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.
    Respir Med; 2014 Oct 01; 108(10):1542-8. PubMed ID: 25269710
    [Abstract] [Full Text] [Related]

  • 19. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug 01; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).
    Rojas-Serrano J, Herrera-Bringas D, Mejía M, Rivero H, Mateos-Toledo H, Figueroa JE.
    Clin Rheumatol; 2015 Sep 01; 34(9):1563-9. PubMed ID: 26219488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.